1. Kim, M.K., et al., Mechanisms driving the antibacterial and antibiofilm properties of Hp1404 and its analogue peptides against multidrug-resistant Pseudomonas aeruginosa. Scientific reports, 2018. 8(1): p. 1-16. 2. Ekrami, A. and E. Kalantar, Bacterial infections in burn patients at a burn hospital in Iran. Indian Journal of Medical Research, 2007. 126(6): p. 541. 3. Morita, Y., J. Tomida, and Y. Kawamura, Responses of Pseudomonas aeruginosa to antimicrobials. Frontiers in microbiology, 2014. 4: p. 422. 4. Farajzadeh Sheikh, R., Meqdadi, Nazarzadeh, Shakoori Fard. , Evaluation of antibiotic susceptibility pattern of Staphylococcus aureus isolated from clinical specimens of patients admitted to Ahvaz teaching hospitals against antibiotics of methicillin, vancomycin, linezolid and macrolides in 2013. Jundishapur Medical Journal,, 2013. 13 (4): p. p.74. (in Persian). 5. Wimley, W.C., Describing the mechanism of antimicrobial peptide action with the interfacial activity model. ACS chemical biology, 2010. 5(10): p. 905-917. 6. Pasupuleti, M., A. Schmidtchen, and M. Malmsten, Antimicrobial peptides: key components of the innate immune system. Critical reviews in biotechnology, 2012. 32(2): p. 143-171. 7. Nabiuni, M., et al., A review onantineoplastic effects of honey bee venom. Zahedan J Res Med Sci, 2012. 13(9): p. 1-7. 8. Subbalakshmi, C., R. Nagaraj, and N. Sitaram, Biological activities of C-terminal 15-residue synthetic fragment of melittin: design of an analog with improved antibacterial activity. FEBS letters, 1999. 448(1): p. 62-66. 9. Lazarev, V., et al., Effect of induced expression of an antimicrobial peptide melittin on Chlamydia trachomatis and Mycoplasma hominis infections in vivo. Biochemical and biophysical research communications, 2005. 338(2): p. 946-950. 10. Yun, S.-W., et al., Melittin inhibits cerulein-induced acute pancreatitis via inhibition of the JNK pathway. International immunopharmacology, 2011. 11(12): p. 2062-2072. 11. Azad, Z.M., et al., In vitro synergistic effects of a short cationic peptide and clinically used antibiotics against drug-resistant isolates of Brucella melitensis. Journal of medical microbiology, 2017. 66(7): p. 919-926. 12. Moghaddam, M.M., et al., Investigation of the antibacterial activity of a short cationic peptide against multidrug-resistant Klebsiella pneumoniae and Salmonella typhimurium strains and its cytotoxicity on eukaryotic cells. World Journal of Microbiology and Biotechnology, 2014. 30(5): p. 1533-1540. 13. Yang, S., et al., Structural analysis and mode of action of BMAP-27, a cathelicidin-derived antimicrobial peptide. Peptides, 2019. 118: p. 170106. 14. Ho Wong, J., X. Juan Ye, and T. Bun Ng, Cathelicidins: peptides with antimicrobial, immunomodulatory, anti-inflammatory, angiogenic, anticancer and procancer activities. Current Protein and Peptide Science, 2013. 14(6): p. 504-514. 15. Sahoo, B.R., et al., Mechanistic and structural basis of bioengineered bovine Cathelicidin-5 with optimized therapeutic activity. Scientific reports, 2017. 7(1): p. 1-16. 16. Benincasa, M., et al., In vitro and in vivo antimicrobial activity of two α-helical cathelicidin peptides and of their synthetic analogs. Peptides, 2003. 24(11): p. 1723-1731. 17. Birla, S., et al., Fabrication of silver nanoparticles by Phoma glomerata and its combined effect against Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus. Letters in Applied Microbiology, 2009. 48(2): p. 173-179. 18. Wiegand, I., K. Hilpert, and R.E. Hancock, Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nature protocols, 2008. 3(2): p. 163-175. 19. Mahlapuu, M., et al., Antimicrobial peptides: an emerging category of therapeutic agents. Frontiers in cellular and infection microbiology, 2016. 6: p. 194. 20. Al Tall, Y., et al., Design and characterization of a new hybrid peptide from LL-37 and BMAP-27. Infection and drug resistance, 2019. 12: p. 1035. 21. Sadri, H., Evaluation of antibiotic resistance of Pseudomonas aeruginosa isolated from patients in Tehran hospitals in 2013. . Bimonthly Journal of Shahed University, , 2013. 23 (121): 37-29 (in persian). 22. Foladi A, R., Shapoori. , Antibiotic resistance and abundance of broad-spectrum beta-lactamases in Pseudomonas aeruginosa strains isolated from clinical specimens. Journal of Ardabil University of Medical Sciences,, 2010. . 10 (3): p. 189-98.(in persian). 23. Bahar, M.A., S. Jamali, and A. Samadikuchaksaraei, Imipenem-resistant Pseudomonas aeruginosa strains carry metallo-β-lactamase gene blaVIM in a level I Iranian burn hospital. Burns, 2010. 36(6): p. 826-830. 24. Sadeghi, A., B. Rahimi, and M. Shojapour, Molecular detection of metallo--lactamase genes blaVIM-1, blaVIM-2, blaIMP-1, blaIMP-2 and blaSPM-1 in Pseudomonas aeruginosa isolated from hospitalized patients in Markazi province by Duplex-PCR. African Journal of Microbiology Research, 2012. 6(12): p. 2965-2969. 25. Gales, A.C., et al., Dissemination in distinct Brazilian regions of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM metallo-β-lactamase. Journal of Antimicrobial Chemotherapy, 2003. 52(4): p. 699-702. 26. Satti, L., et al., In vitro efficacy of Cefepime against multi-drug resistant Pseudomonas aeruginosa–an alarming situation in our setup. The Open Drug Resistance Journal, 2011. 1(1). 27. Ozer, B., et al., Efflux pump genes and antimicrobial resistance of Pseudomonas aeruginosa strains isolated from lower respiratory tract infections acquired in an intensive care unit. The Journal of antibiotics, 2012. 65(1): p. 9-13. 28. Mahfoud, M., M. Al Najjar, and A.R. Hamzeh, Multidrug resistance in Pseudomonas aeruginosa isolated from nosocomial respiratory and urinary infections in Aleppo, Syria. The Journal of Infection in Developing Countries, 2015. 9(02): p. 210-213. 29. Shahcheraghi F, N.V., Metalobetalactamase enzyme and detection the resistance to ceftazidime and imipenem antibiotics in Pseudomonas aeruginosa isolated from clinical speciments in hospital of Imam khomeini and pediatrics medical center in 2005. Iranian Journal of Infectious Disease and Tropical Medicine. ;, 2007. 12((36): ): p. 19-22. 30. Anjum, F. and A. Mir, Susceptibility pattern of Pseudomonas aeruginosa against various antibiotics. African Journal of Microbiology Research, 2010. 4(10): p. 1005-1012. 31. Amiri, A., Evaluation of drug resistance of Staphylococcus aureus strains resistant to the antibiotic vancomycin in some hospitals in Rasht. Journal of Medical Sciences,, 2018. . 28 (1): : p. p. 74-80. (in Persian). 32. Tabaei, N.K., Mohammadzadeh, Atai, Dar Aj, Saeed. Mashhad. Journal of Mashhad University of Medical Sciences, , Pattern of antibiotic resistance in methicillin-resistant Staphylococcus aureus strains isolated from clinical specimens: Imam Reza (AS) Hospital, . 2016. . 59 (2):: p. p. 64-70. (in Persian). 33. Nourbakhsh F, M.H., Detection of antibiotic resistance patterns in Staphylococcus aureus strains isolated from patients admitted to Isfahan hospitals during 2014-2015. Feyz., 2015. 19 (4) :: p. p. 356-363.(in Persian). 34. Javadmanesh, M., Tanhayan, Abbas, Azghandi, Marjan. , Comparison of antibacterial effects of tanatine peptide with two essential oils of cinnamon and oregano on isolates of pathogenic bacteria. . Veterinary research and biological products,, 2020. 33 (1): p. p. 47-53. (in Persian). 35. Gholami A, A.M.R., Ahmadi M. , Evaluation of antibacterial activity of aqueous and methanol extracts of Allium Jesdianum plant on a number of pathogenic bacteria resistant to antibiotics. . psj,, 2016. 14 (4) :: p. p. 18-26. (in Persian). 36. Tian, Z.-g., et al., Design and characterization of novel hybrid peptides from LFB15 (W4, 10), HP (2-20), and cecropin A based on structure parameters by computer-aided method. Applied microbiology and biotechnology, 2009. 82(6): p. 1097-1103. 37. Wanmakok, M., et al., Expression in Escherichia coli of novel recombinant hybrid antimicrobial peptide AL32-P113 with enhanced antimicrobial activity in vitro. Gene, 2018. 671: p. 1-9. 38. Faccone, D., et al., Antimicrobial activity of de novo designed cationic peptides against multi-resistant clinical isolates. European journal of medicinal chemistry, 2014. 71: p. 31-35. 39. Jiang, X., et al., Design and activity study of a melittin–thanatin hybrid peptide. AMB Express, 2019. 9(1): p. 1-6. 40. Wu, R., et al., Design, characterization and expression of a novel hybrid peptides melittin (1–13)-LL37 (17–30). Molecular biology reports, 2014. 41(7): p. 4163-4169.
مجله علوم پزشکی پارس
)